Deutsche Bank’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $198K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $195K | Buy |
|
|||||
|
2024
Q2 | $110K | Sell |
|
|||||
|
2024
Q1 | $293K | Buy |
|
|||||
|
2023
Q4 | $141K | Sell |
|
|||||
|
2023
Q3 | $94.8K | Sell |
|
|||||
|
2023
Q2 | $1.17M | Buy |
|
|||||
|
2023
Q1 | $345K | Sell |
|
|||||
|
2022
Q4 | $2.36M | Buy |
|
|||||
|
2022
Q3 | $5M | Buy |
|
|||||
|
2022
Q2 | $3.42M | Sell |
|
|||||
|
2022
Q1 | $5.77M | Sell |
|
|||||
|
2021
Q4 | $8.92M | Sell |
|
|||||
|
2021
Q3 | $47.9M | Buy |
|
|||||
|
2021
Q2 | $68.7M | Buy |
|
|||||
|
2021
Q1 | $14.1M | Buy |
|
|||||
|
2020
Q4 | $5.29M | Sell |
|
|||||
|
2020
Q3 | $5.8M | Sell |
|
|||||
|
2020
Q2 | $11.7M | Buy |
|
|||||
|
2020
Q1 | $1.59M | Buy |
|
|||||
|
2019
Q4 | $440K | Buy |
|
|||||
|
2019
Q3 | $280K | Sell |
|
|||||
|
2019
Q2 | $442K | Sell |
|
|||||
|
2019
Q1 | $2.14M | Buy |
|
|||||
|
2018
Q4 | $343K | Sell |
|
|||||
|
2018
Q3 | $3.43M | Buy |
|
|||||
|
2018
Q2 | $1.1M | Buy |
|
|||||
|
2018
Q1 | $635K | Sell |
|
|||||
|
2017
Q4 | $527K | Buy |
|
|||||
|
2017
Q3 | $138K | Sell |
|
|||||
|
2017
Q2 | $141K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $30K | Sell |
|
|||||
|
2016
Q1 | $78K | Buy |
|
|||||
|
2015
Q4 | $21K | Sell |
|
|||||
|
2015
Q3 | $73K | Sell |
|
|||||
|
2015
Q2 | $166K | Buy |
|
|||||
|
2015
Q1 | $72K | Sell |
|
|||||
|
2014
Q4 | $154K | Buy |
|
|||||
|
2014
Q3 | $135K | Buy |
|
|||||
|
2014
Q2 | $154K | Buy |
|
|||||
|
2014
Q1 | $164K | Sell |
|
|||||
|
2013
Q4 | $115K | Buy |
|